Interest in calcium as a chemopreventive agent in colorectal carcinoma began in 1982 when a Scandinavian study showed that the cancer incidence was least in populations consuming a diet rich in diary products despite a high fat intake.' Three years later, Garland's 19 year prospective dietary study on 1954 men from Chicago concluded that a high calcium intake (>1.5 g/day) was associated with a 65% reduction in cancer incidence.2 It seems that populations consuming high calcium diets may enjoy a relative freedom from colon cancer.
Experimental work in our laboratory has reinforced some of these findings. Doubling the calcium intake in rats by adding 24 g/l to the drinking water halves the yield of colorectal tumours induced by azoxymethane.3 There is a corresponding fall in crypt cell production rate in both right and left colon. 4 Recent data from elsewhere show a similar effect. 5 Calcium can also modify the behaviour of cell lines Calcium concentration (mmol/l) Figure 2 : Crypt cell production rate in organ culture. *p<O.OS vGCa2+ =2 l4, p<O 02 vCa =4-28.
Two recent studies in which colorectal carcinogenesis was stimulated by dietary augmentation with bile acids and fats are in concordance with our data. A threefold increase in dietary calcium in rats receiving parenteral N-methyl-N-nitrosourea failed to reverse the tumour enhancing effect of oral cholic acid.28 By contrast, the tumour promoting effect of a high fat diet was completely reversed by doubling oral calcium intake.5 It thus seems probable that calcium does not bind free bile acids in the small bowel or that there is preferential binding of free fatty acids. Some of the data of McSherry et a128 are controversial, as raised dietary calcium actually enhanced tumour yields in some groups. However, the dose of N-methyl-N-nitrosourea (and the yield of colorectal tumours) was small in this experiment, and calcium concentrations in the control diet were higher than in ours (O 56%). Wargovich emphasises the need for calcium concentrations in control rats to match 'human nutrient density'.29 Most commercially available animal feeds have calcium concentrations up to tenfold those in normal human diet. 30 It is interesting that calcium lowers the birth rate of colonic mucosa in organ culture. A recent (autoradiographic) study of cultured rectal biopsy specimens from 'high risk' patients showed a similar effect: the high labelling indices usually found in these patients were reduced to normal when the concentration of calcium in the culture medium was doubled.3' Higher concentrations of calcium (and vitamin D3) lead to increased differentiation in a cell line derived from a human colorectal carcinoma,32 although malignant epidermal cells do not respond to calcium fluctuations.6 It is proposed that calcium prevents loss of cell to cell contact by preserving tight junctions, thus inhibiting cell proliferation.29 Any 'direct' effect of calcium is unlikely to be mediated systemically, since serum concentrations were unchanged in this and previous studies in our laboratory.3 Although the relative contributions of 'direct' and 'indirect' effects of intraluminal calcium on colonic adaptation and carcinogenesis are unknown, evidence for a direct antitropic effect of calcium on colorectal mucosa (and many other epithelia) is now substantial. Indeed, sufficient animal data are available to justify more trials on human subjects. There are no obvious contraindications to oral calcium supplements of 1-2 g/ day. Urinary lithiasis is not provoked; in fact it is actually inhibited in patients with a tendency to form oxalate stones.33 Calcium may have the added benefit of reducing blood pressure in some hypertensive patients. 34 The evaluation of colonic cytokinetics has great potential in the identification of 'high risk' patients. Lipkin and Newmark's encouraging results indicating a possible prophylactic role for calcium35 may have profound implications for general dietary advice.
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